| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |